Stirling
Management
School
COVID 19 (Coronavirus)
Find out more about important changes, additional start dates and our commitment to making our campus safer for 2020.
Stirling Management School’s reputation for excellence is reflected in our rankings. We’re rated among the top 10 Universities in the UK for Economics, Marketing and Human Resource Management, and the top 5 in Scotland for Business Studies, Accounting and Finance and overall research impact. Our close links with industry, range of professional accreditations and memberships with leading management education bodies help to ensure all our teaching is relevant in the real world and tailored towards your future success.
Economics - 3rd in Scotland, Top 5 in the UK
The Guardian University Guide 2021
Accounting and Finance - 3rd in Scotland
The Times and Sunday Times Good University Guide 2021
Marketing - 2nd in Scotland, top 10 in the UK
The Complete University Guide 2021
Our memberships
Study with us
With professionally focused courses across all management subjects, we have qualifications to suit every stage of your career. From undergraduate degrees, to our full-time accredited Master of Business Administration (MBA), our courses equip you with the knowledge you need to make a difference to organisations around the world.
Your future career
Maximise your career after graduation by gaining the knowledge you need to make a difference to SMEs, family businesses and major global organisations.
Business connections
For more than 30 years we’ve been making a difference to organisations and professionals through our world-class executive management education.
News
Fiscal frameworks of UK devolved governments must be made more robust to future crises, experts say
Economic experts have warned that the fiscal frameworks of the UK’s devolved governments must be made more robust to future crises and better able to support COVID-19 recovery.
Change in AstraZeneca UK regulation for under 30s did not impact vaccine intentions
New research from the University of Stirling shows that the change in UK regulation of the AstraZeneca vaccine – recommending an alternative for those under 30 – has had no effect on the general public’s intention to get vaccinated.